Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Champions Oncology (CSBR) Change in Account Payables (2016 - 2026)

Champions Oncology has reported Change in Account Payables over the past 17 years, most recently at -$437000.0 for Q1 2026.

  • Quarterly results put Change in Account Payables at -$437000.0 for Q1 2026, down 132.45% from a year ago — trailing twelve months through Jan 2026 was $671000.0 (up 829.35% YoY), and the annual figure for FY2025 was -$1.7 million, down 476.13%.
  • Change in Account Payables for Q1 2026 was -$437000.0 at Champions Oncology, down from $1.3 million in the prior quarter.
  • Over the last five years, Change in Account Payables for CSBR hit a ceiling of $2.1 million in Q4 2022 and a floor of -$1.2 million in Q4 2023.
  • Median Change in Account Payables over the past 5 years was -$188000.0 (2025), compared with a mean of $113764.7.
  • Peak annual rise in Change in Account Payables hit 1443.28% in 2022, while the deepest fall reached 635.57% in 2022.
  • Champions Oncology's Change in Account Payables stood at $2.1 million in 2022, then tumbled by 159.19% to -$1.2 million in 2023, then skyrocketed by 68.79% to -$382000.0 in 2024, then soared by 443.19% to $1.3 million in 2025, then crashed by 133.33% to -$437000.0 in 2026.
  • The last three reported values for Change in Account Payables were -$437000.0 (Q1 2026), $1.3 million (Q4 2025), and $411000.0 (Q3 2025) per Business Quant data.